Skip to main content
PAS 2025 Meeting Main banner
Final Program


Schedule at a Glance
Icon Legend
Presentation Icons
Ticketed Event
Ticketed Event
Back
Evaluation ViewAttendees 59

Critical Care

Emergency Medicine

General Pediatrics

Hospital Medicine

Infectious Diseases

Neonatology

Nephrology

Pulmonology

Trainee
Session Type: Basic-Translational-Clinical Roundtable

Procalcitonin in Pediatrics

Sunday, April 27, 2025
10:45am – 12:15pm HST
Location: Convention Center: Kalākaua Ballroom B (Level 4)
CE: 1.5

Selected By: CC
Co-sponsored By: PIDS, PHM, Critical Care, CHTRC
Disclosure(s):
Nisha Gupta, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Procalcitonin is a biomarker that has been well-studied in the adult population and has gained increased attention in the pediatric population over the past two decades. This session aims to have participants critically review pre-identified studies and determine the role of procalcitonin in key clinical scenarios.

This session will start with a 10-minute review of the pathophysiology and kinetics of procalcitonin. Following this, participants at each roundtable will spend 20 minutes reviewing 1-2 fundamental articles that describes the potential role of procalcitonin in the evaluation and management of one of the following diagnoses: lower respiratory tract infections, musculoskeletal infections, febrile infants, vesicoureteral reflux, and sepsis severity. Then, each roundtable will spend 20 minutes discussing as a group how the findings from the article(s) can be integrated into clinical practice. Each roundtable will share with the large group a summary of the article(s) and conclusions with additional insight reviewed by the presenters. The last 10 minutes will be a Q&A. Participants will be given access to an electronic folder of all the articles reviewed.

Learning Objectives:

  • Review the pathophysiology and kinetics of procalcitonin production
  • Demonstrate the clinical applications of procalcitonin including: lower respiratory tract infections, musculoskeletal infections, febrile infants, vesicoureteral reflux, and sepsis severity
  • Discuss potential applications of procalcitonin into clinical practice including integration into clinical practice pathways/guidelines

Presentations:

  • 10:45am – 11:10am HST
    Clinical Applications of Procalcitonin in Pediatrics

    Speaker: Nisha Gupta, MD (she/her/hers) – Inova Children's Hospital

  • 11:10am – 11:45am HST
    Clinical Applications of Procalcitonin in Pediatrics

    Speaker: Christine Klingaman, D.O. – Inova Children's Hospital

  • 11:45am – 12:15pm HST
    Clinical Applications of Procalcitonin in Pediatrics

    Speaker: Kamilah Halmon, MD – Inova Children's Hospital